CalciMedica Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	43	16	11	39	609
Market Cap Growth	468.72%	50.81%	-72.37%	-93.59%	-
Enterprise Value	17	5	14	-25	514
PE Ratio	-	-0.47	-1.18	-1.09	-17.53
PB Ratio	2.50	1.99	-0.15	0.60	6.42
P/FCF Ratio	-1.78	-0.63	-0.92	-1.22	-18.40
P/OCF Ratio	-1.78	-0.63	-0.92	-1.24	-18.99
EV/EBITDA Ratio	-1.27	-0.15	-1.86	0.70	-18.93
EV/EBIT Ratio	-1.27	-0.15	-1.85	0.69	-18.66
EV/FCF Ratio	-0.75	-0.19	-1.23	0.77	-15.53
Debt / Equity Ratio	-	-	-0.07	-	-
Debt / EBITDA Ratio	-	-	-0.66	-	-
Debt / FCF Ratio	-	-	-0.44	-	-
Quick Ratio	6.00	2.79	0.31	15.69	13.58
Current Ratio	6.21	2.88	0.36	16.53	14.18
Return on Equity (ROE)	-111.10%	-234.70%	-48.00%	-47.70%	850.10%
Return on Assets (ROA)	-79.20%	-165.70%	-22.40%	-44.90%	-48.70%
Return on Capital (ROIC)	-124.67%	-466.78%	21.46%	-55.28%	-31.47%
Earnings Yield	-34.66%	-211.31%	-84.80%	-91.81%	-5.70%
FCF Yield	-58.39%	-158.73%	-109.09%	-81.99%	-5.43%
Buyback Yield / Dilution	-1120.73%	-5354.75%	94.57%	-220.31%	-401.43%
Total Shareholder Return	-1120.73%	-5354.75%	94.57%	-220.31%	-401.43%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).